Midazolam in 0.9% Sodium Chloride - (50 mg/50 mL and 100 mg/100 mL ; Intravenous)

Generic Name	Midazolam	Innovator	INFORLIFE
Dosage	50 mg/50 mL and 100 mg/100 mL ; Intravenous	Branded US Sales	Less Than $1000 mn
Probable FTF	Less Than 5	Known Para IV Filers	Less Than 5
Other ANDA developers	None	Tentative Approvals	None
Final Approvals	Less Than 5	Generic Launches	Less Than 5
Indication	None
Complexities	No

Executive Summary

Patent Status

Launch Timelines and Competition

Company	FTF Status / 180 days exclusivity	30-Months stay	Current Litigation Status	Current Approval Status	Likelihood of launch
*** ******	***(*)(*)	*** **, ****	*******	****	******* *** **** *** *** ****
*****	*** \ ***	*** **, ****	*******	********	******** ** *** **, ****

Chronology Of Events